Pfizer Other Current Assets 2010-2024 | PFE

Pfizer other current assets for the quarter ending September 30, 2024 were $7.098B, a 16.89% decline year-over-year.

  • Pfizer other current assets for 2023 were $9.277B, a 7.95% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.
  • Pfizer other current assets for 2021 were $3.82B, a 4.77% increase from 2020.

Pfizer Other Current Assets 2010-2024 | PFE

  • Pfizer other current assets for 2023 were $9.277B, a 7.95% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.
  • Pfizer other current assets for 2021 were $3.82B, a 4.77% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B